HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masafumi Taniwaki Selected Research

Masafumi Taniwaki Research Topics

Disease

41Neoplasms (Cancer)
12/2023 - 05/2002
41Multiple Myeloma
03/2022 - 04/2003
25Lymphoma (Lymphomas)
01/2022 - 01/2003
17Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020 - 03/2004
15Leukemia
06/2021 - 05/2002
14BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2017 - 01/2004
13Chromosome Aberrations (Chromosome Abnormalities)
01/2018 - 05/2003
12Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2024 - 06/2005
12Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2023 - 04/2004
11Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 07/2002
10Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2020 - 09/2010
9Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 09/2007
9Genetic Translocation (Chromosomal Translocation)
01/2016 - 04/2003
8B-Cell Lymphoma (Lymphoma, B Cell)
06/2021 - 05/2003
8Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018 - 06/2004
8Infections
02/2017 - 12/2004
8Philadelphia Chromosome
01/2016 - 09/2006
7Fever (Fevers)
11/2016 - 05/2003
6Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 05/2002
6Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2022 - 07/2008
6Carcinogenesis
01/2020 - 01/2006
6Disease Progression
01/2019 - 06/2008
6Anemia
06/2018 - 10/2009
6Thrombocytopenia (Thrombopenia)
12/2016 - 10/2009
5Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2019 - 04/2007
5Hepatocellular Carcinoma (Hepatoma)
01/2013 - 02/2009
4B-Cell Leukemia (Leukemia, B Cell)
01/2022 - 07/2005
4Neutropenia
12/2016 - 10/2007
4Peripheral Nervous System Diseases (PNS Diseases)
03/2016 - 10/2010
4T-Cell Lymphoma (Lymphoma, T Cell)
04/2014 - 05/2003
4Diarrhea
01/2009 - 03/2004
4Febrile Neutropenia
05/2008 - 12/2007
3Burkitt Lymphoma (Burkitt's Lymphoma)
10/2023 - 05/2005
3Hypertension (High Blood Pressure)
01/2022 - 03/2016
3Residual Neoplasm
11/2017 - 05/2002
3Pleural Effusion (Pleural Effusions)
06/2017 - 03/2005
3Body Weight (Weight, Body)
11/2016 - 04/2008
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2016 - 04/2004
3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
07/2015 - 04/2007
3Pathologic Complete Response
04/2013 - 07/2005
3Disseminated Intravascular Coagulation
04/2013 - 01/2011
3Lymphadenopathy
03/2012 - 06/2004
3Stomach Neoplasms (Stomach Cancer)
02/2010 - 02/2002
2Frailty
03/2022 - 01/2022
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2017 - 04/2014

Drug/Important Bio-Agent (IBA)

25Rituximab (Mabthera)FDA Link
01/2022 - 06/2004
18Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 01/2006
17Proteins (Proteins, Gene)FDA Link
10/2023 - 07/2002
15Bortezomib (Velcade)FDA Link
01/2022 - 06/2008
13Lenalidomide (CC 5013)FDA Link
01/2022 - 10/2009
9Imatinib Mesylate (Gleevec)FDA Link
06/2017 - 09/2006
9ParaffinIBA
02/2006 - 02/2002
8DNA (Deoxyribonucleic Acid)IBA
01/2018 - 07/2004
8Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
04/2011 - 04/2003
7carfilzomibIBA
03/2022 - 03/2016
7Prednisolone (Predate)FDA LinkGeneric
01/2020 - 05/2003
7Vincristine (Oncovin)FDA LinkGeneric
12/2018 - 05/2003
7Doxorubicin (Adriamycin)FDA LinkGeneric
11/2018 - 05/2003
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2018 - 05/2003
6Phosphotransferases (Kinase)IBA
10/2023 - 12/2012
6Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2018 - 01/2006
6Dasatinib (BMS 354825)FDA Link
06/2017 - 04/2009
5Melphalan (Alkeran)FDA LinkGeneric
01/2020 - 06/2008
5Bendamustine HydrochlorideFDA Link
07/2019 - 09/2010
5Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2019 - 05/2005
4Cyclin D1IBA
01/2020 - 04/2003
4Prednisone (Sone)FDA LinkGeneric
11/2018 - 06/2005
4Tyrosine Kinase InhibitorsIBA
11/2017 - 07/2010
4Thalidomide (Thalomid)FDA Link
05/2016 - 06/2009
4Monoclonal AntibodiesIBA
08/2015 - 03/2005
4Immunoglobulins (Immunoglobulin)IBA
04/2014 - 05/2002
4OligonucleotidesIBA
10/2010 - 02/2009
4Anti-Bacterial Agents (Antibiotics)IBA
11/2006 - 03/2004
3Phosphatidylinositols (Phosphatidylinositol)IBA
10/2023 - 12/2014
3pomalidomideIBA
06/2021 - 01/2015
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2020 - 12/2014
3Cytarabine (Cytosar-U)FDA LinkGeneric
09/2018 - 01/2006
3elotuzumabIBA
01/2018 - 09/2013
3nilotinibFDA Link
11/2017 - 01/2015
3CreatinineIBA
11/2016 - 04/2008
3AntigensIBA
01/2016 - 12/2004
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2015 - 05/2002
3Dacarbazine (DIC)FDA LinkGeneric
04/2013 - 04/2009
3Immunoglobulin G (IgG)IBA
12/2006 - 03/2005
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2015
2Transcription Factors (Transcription Factor)IBA
01/2022 - 06/2004
2RNA (Ribonucleic Acid)IBA
06/2021 - 01/2016
2forodesineIBA
01/2019 - 12/2018
2Protein Kinases (Protein Kinase)IBA
01/2018 - 12/2014
23-Phosphoinositide-Dependent Protein KinasesIBA
01/2018 - 12/2014
2Indicators and Reagents (Reagents)IBA
11/2017 - 01/2006

Therapy/Procedure

54Therapeutics
03/2024 - 01/2003
35Drug Therapy (Chemotherapy)
01/2022 - 05/2002
9Stem Cell Transplantation
09/2018 - 01/2004
4Hematopoietic Stem Cell Transplantation
01/2017 - 01/2009
4Transplantation
01/2016 - 04/2004
4Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2010 - 05/2005
3Aftercare (After-Treatment)
11/2018 - 01/2006
3Cell Transplantation
02/2017 - 04/2013
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2012 - 05/2003